activity against hepatitis C virus (HCV).•Some compounds exhibited strong inhibition against
HCV 1b and 2a genotypes.•The hydrazide–hydrazone derivatives were shown to inhibit
cellular growth of liver cancer cells.
Highlights
- We synthesized new diflunisal hydrazide–hydrazones.
- We investigated their activity against hepatitis C virus (HCV).
- Some compounds exhibited strong inhibition against HCV 1b and 2a genotypes.
- The hydrazide–hydrazone derivatives were shown to inhibit cellular growth of liver cancer cells.